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Synthetic biology aims to systematically design and construct novel biological systems that address
energy, environment, and health issues. Herein, we describe the development of a synthetic genetic
system, which comprises quorum sensing, killing, and lysing devices, that enables Escherichia coli
to sense and kill a pathogenic Pseudomonas aeruginosa strain through the production and release of
pyocin. The sensing, killing, and lysing devices were characterized to elucidate their detection,
antimicrobial and pyocin release functionalities, which subsequently aided in the construction of
the ﬁnal system and the veriﬁcation of its designed behavior. We demonstrated that our engineered
E. coli sensed and killed planktonic P. aeruginosa, evidenced by 99% reduction in the viable cells.
Moreover, we showed that our engineered E. coli inhibited the formation of P. aeruginosa bioﬁlm by
closeto90%,leadingtomuchsparserandthinnerbioﬁlmmatrices.TheseresultssuggestthatE.coli
carrying our synthetic genetic system may provide a novel synthetic biology-driven antimicrobial
strategy that could potentially be applied to ﬁghting P. aeruginosa and other infectious pathogens.
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Introduction
Synthetic biology aims to engineer genetically modiﬁed
biological systems that perform novel functions that do not
exist in nature, with reusable, standard interchangeable
biological parts. The use of these standard biological parts
enables the exploitation of common engineering principles
such as standardization, decoupling, and abstraction for
synthetic biology (Endy, 2005). With this engineering frame-
work in place, synthetic biology has the potential to make the
constructionofnovelbiologicalsystemsapredictable,reliable,
systematic process. While the development of most synthetic
biological systems remains largely ad hoc, recent efforts to
implement an engineering framework in synthetic biology
have provided long-awaited evidences that engineering
principles can facilitate the construction of novel biological
systems. Synthetic biology has so far demonstrated that its
framework can be applied to a wide range of areas such as
energy, environment, and health care. For example, novel
biological systems have been constructed to produce drugs
(Ro et al, 2006) and biofuels (Steen et al, 2010), to degrade
containments in water (Sinha et al, 2010), and to kill cancer
cells (Anderson et al, 2006).
Despite these encouraging advances, synthetic biology has
not yet been exploited to develop new strategies for tackling
infectious disease, a leading cause of death worldwide,
especially in poor countries. Given the stalled development
of new antibiotics and the increasing emergence of multidrug-
resistant pathogens, using synthetic biology to design new
treatment regimens for infectious disease could address an
urgent need. Consequently, in this study, we have made
progress toward developing a novel antimicrobial strategy,
based on an engineered microbial system, using the synthetic
biology framework. Toward this aim, we designed and
constructed a genetic system, based on standardization,
decoupling, and abstraction, that allows sensing and killing
of Pseudomonas aeruginosa, a human pathogen, in a non-
pathogenicchassis,Escherichiacoli.Thebiologicalpartsofour
devicesweredesigned and synthesized in compliancewith the
BioBrick assembly standards (Canton et al, 2008). Each of the
biological devices was characterized to understand its
behavior, and the correlation between the input and output
of one key biological device was studied in detail.
P. aeruginosa colonizes the respiratory and gastrointestinal
tract (Fujitani et al, 2011), and causes life-threatening
infections to the patients with immunodeﬁciency such as
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2007). Despite a wide range of antibiotics available in the
market, P. aeruginosa is still among the leading causes of
nosocomial infection primarily because it is intrinsically
resistant to many antibiotics and antimicrobials, in part
because of its effective efﬂux systems (Chang et al, 2005b).
Contemporary treatments against P. aeruginosa infection
include antibiotic chemotherapy and bacteriophage therapy.
In antibiotic chemotherapy, a combinatorial treatment invol-
ving multiple antimicrobial agents is usually preferred over
monotherapy due to the rapid acquisition of drug tolerance in
P. aeruginosa. This approach, however, promotes unspeciﬁc
killing of bacteria and upsets a healthy human microbiome.
Phage therapy involves strain-speciﬁc bacteriophages that
invade and destroy the cellular integrity of pathogens (Wright
et al, 2009). The therapeutic potential of employing virus in
bacterial infection, however, is limited, as a directed treatment
cannotbere-employedaftertheinfectedhostdevelopsspeciﬁc
antibodies against the introduced virus (Ha ¨usler, 2006).
Certainly, combating P. aeruginosa infections now requires
the development of novel, unconventional antimicrobial
strategies that do not entirely rely on current antibiotics.
To this end, we have exploited P. aeruginosa’s ownstrategy for
survival in a competitive environment by means of bacter-
iocins, ribosomally synthesized antimicrobial peptides. Bac-
teriocins are speciﬁc and effective against closely related
species, and thus have garnered attention as a new generation
antibacterial agent (Baba and Schneewind, 1998). Pyocins are
narrow-spectrum bacteriocins produced by P. aeruginosa.
Contrary to traditional antibiotics, the acquisition of pyocin
resistance bylateral gene transfer betweenbacteria has not yet
been encountered, supporting the use of pyocins in targeting
P. aeruginosa infection (Scholl and Martin, 2008). In general,
pyocins are classiﬁed into three types: R, F, and S. An earlier
study estimated that R and F type pyocins are synthesized by
90%ofallP.aeruginosastrainsandStypeby70%(Smithetal,
1992). S-type pyocins are soluble and comprise two protein
molecules associated in complex, with parallel structural and
functional features similar to DNase-based colicins. The larger
protein has been identiﬁed as the functional protein for killing
while the smaller protein is regarded as the immunity protein
that confers the host cell with defense mechanism against its
own pyocin (Seo and Galloway, 1990). Our group has recently
reported that pyocin S5 exhibits strong bactericidal activity
against P. aeruginosa clinical isolates through membrane
damage but is ineffective against E. coli (Ling et al, 2010).
Together with its characteristics of being soluble and medium
sized at 498 amino acids, pyocin S5 presents itself as an ideal
candidate for a killing molecule in an E. coli chassis.
Further, to enable our engineered microbes to produce
pyocinS5only inresponsetothe presence ofP.aeruginosa,w e
exploited the quorum sensing mechanisms of P. aeruginosa.
Quorum sensing is an organic chemical signaling cascade that
regulates a myriad of physiological activities such as cell
motility, virulence, bioﬁlm formation, and growth (Chang
et al, 2005b). This sensing mechanism is mediated by various
diffusible, chemical signals known as autoinducers that are
produced by the synthase genes of the bacteria. The
extracellular concentration of signaling molecules increases
as a function of cell density and is permeable to cell
membrane. Upon attaining a threshold concentration of the
chemical signals, the quorum sensing cascade is activated to
elicit expressions or repressions of multiple genes, including
those that are functional for production of autoinducers such
as acyl homoserine lactones (AHLs; Asad and Opal, 2008).
Although similar production mechanisms are present in some
Gram-negative bacteria, each synthase homolog producing
AHLs differs in either length or functional groups (e.g.,
hydroxyl and carbonyl groups) on the acyl side chain. Thus,
with each bacterium possessing disparate synthase sequence,
a high level of speciﬁcity can be achieved during intercellular
quorum communication (Schuster, 2004; Smith et al, 2008).
To enable an effective release of pyocin S5, we utilized E7
lysis protein to lyse the E. coli chassis. The E7 lysis protein is a
key component of the SOS response system in colicin-
producing cells and functions to export bacteriocins into the
extracellular space under stressful environmental conditions
(Chak et al, 1991). Recent studies have shown that the E7 lysis
protein is effective in causing inner membrane damage and
maybe associated with the activation of outer membrane
phospholipase A for outer membrane modiﬁcation (Lin et al,
2009). In addition to being speciﬁc to E. coli, the E7 lysis
protein is small at 47 amino acids and can be easily utilized as
a modular part in the assembly of novel genetic circuits.
Taken together, our ﬁnal system was designed to (i) detect
AHLs produced by P. aeruginosa; (ii) produce pyocin S5 upon
the detection; and (iii) lyse the E. coli cells by E7 lysis protein
so that the produced pyocin S5 is released from the cells,
leading to the killing of P. aeruginosa. In this paper, we
demonstrate that our engineered E. coli effectively senses and
kills P. aeruginosa, which provides a novel synthetic biology-
based antimicrobial strategy that could be applied to eradicat-
ing other infectious pathogens.
Results and discussion
Design of the sensing and killing genetic system
Figure 1 shows a schematic of our sensing and killing genetic
system. The sensing device was designed based on the Type I
quorum sensing mechanism of P. aeruginosa. The tetR
promoter, which is constitutively on, produces a transcrip-
tional factor, LasR, that binds to AHL 3OC12HSL. The luxR
promoter, to which LasR-3OC12HSL activator complex report-
edly binds, was adopted as the inducible promoter in our
sensing device (Gray et al, 1994). Next, the formation of the
LasR-3OC12HSL complex, which binds to the luxR promoter,
activates the killing and lysing devices, leading to the
production of pyocin S5 and lysis E7 proteins within the
E. coli chassis. Upon reaching a threshold concentration, the
lysis E7 protein perforates membrane of the E. coli host and
releases the accumulated pyocin S5. Pyocin S5, which is a
soluble protein, then diffuses toward the target pathogen and
damagesitscellularintegrity,therebykillingit.Supplementary
Figure 1A shows the plasmid map of the ﬁnal system.
Characterization of the sensing device
To evaluate and characterize the sensing device, the gene
encoding the green ﬂuorescent protein (GFP) was fused to the
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is shown in Supplementary Figure 1B) and the GFPexpression
wasmonitoredatarangeofconcentrationsof3OC12HSL.From
the measured GFP synthesis rates (Figure 2A), we observed a
basal expression level of 0.216RFU per OD per minute without
induction, followed by a sharp increasein GFP production rate
as the concentration of 3OC12H S Lw a si n c r e a s e db e y o n d1 . 0 E - 7M .
This transition peaked at 1.0E-6M of 3OC12HSL and exhibited
a sharp decline afterward. These results suggest that the
optimal detection range of the sensing device was between
1.0E-7 and 1.0E-6M 3OC12HSL. Note that previous studies
estimated extracellular concentration of 3OC12HSL to be in the
range of 1.0E-6 to 1.0E-4M within proximity to the site of
P. aeruginosa infection (Pearson et al, 1995; Charltonet al, 2000).
Transfer function of the sensing device
One important characteristic of the sensing device was the
transfer function that describes the static relationship between
the input (3OC12HSL) and output (GFP production rate) of the
sensingdevice.Thetransferfunctionwasdeterminedbyﬁtting
an empirical mathematical model (Hill equation) to the
experimental data where the input 3OC12HSL concentration
is o1.0E-6M. The resulting best ﬁt model demonstrated that
the static performance of the sensing device follows a Hill
equation below the input concentration of 1.0E-6M 3OC12HSL
(Figure 2B). The model showed that the sensing device
saturated at a maximum output of 1.96RFU per OD per
minute at input concentration 43.3E-7M but o1.0E-6M
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Figure 2 Characterization results of sensing device coupled with GFP reporter. (A) GFP production rate per cell over time at different 3OC12HSL inducer
concentrations. (B) Time-averaged GFP production rate per cell at different input 3OC12HSL concentrations, showing that the optimal operating concentrations for the
sensing device range from 1.0E-7 to 1.0E-6M 3OC12HSL. Error bar represents the standard deviation of statistical means between 20 and 80m after induction. The
experiment was performed with six replicates. Source data is available for this ﬁgure at www.nature.com/msb.
Our engineered E. coli
P. aeruginosa 
PluxR lasR Lysis E7  Pyocin S5
PluxR PtetR
3OC12 HSL
Pyocin S5 protein
Lysis E7 protein 
lasR protein
PluxR activator Quorum sensing
Pathogen inhibition
Lysis activation Pyocin accumulation
Figure1 Schematicof‘PathogenSensingandKilling’system.luxRpromoterisactivatedbyLasR-3OC12HSLcomplex,leadingtoproductionofE7lysisproteinandS5
pyocin within E. coli chassis. After the E7 protein attains the threshold concentration that causes the chassis to lyse, the accumulated S5 is released into the exogenous
environment and kills P. aeruginosa.
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1.2E-7M3OC12HSL,theinputconcentrationatwhichoutputis
at half-maximal. Since this switch point concentration is
smaller than the concentration of 3OC12HSL present (1.0E-6 to
1.0E-4M) within proximity to the site of P. aeruginosa
infection as earlier reported in the literature (Pearson et al,
1995; Charlton et al, 2000), the sensing device would be
sensitive enough to detect the amount of 3OC12HSL natively
produced by P. aeruginosa.
Detection of the native autoinducer produced by
P. aeruginosa
As stated above, the characterization of the sensing device
indicated that it produced an optimal output at 1.0E-7 to 1.0E-
6M 3OC12HSL. To verify that the sensing device would be able
to sense the amount of 3OC12HSL natively produced by P.
aeruginosa, the sensing device coupled with a GFP reporter
(i.e., pTetR-LasR-pLuxR-GFP) was induced using the ﬁltered
cultureofP.aeruginosaln7, aclinical isolatethatissensitiveto
pyocin S5 (Ling et al, 2010). Results show that GFP synthesis
rate measured for the isolate ln7 was 1.375RFU per OD per
minute. This valuewas above the minimum synthesis rate and
greaterthanthehalf-maximalofthesensingdevice.Thisresult
conﬁrmed that the sensing device was able to detect the
natively produced 3OC12HSL. Further, we used the GFP
synthesis rate measured and the model (Equation 1, Materials
and methods) derived in the earlier experiment to gain an
insight into the amount of 3OC12HSL natively produced by the
isolate. The average concentration of 3OC12HSL in the liquid
culture of the P. aeruginosa strain was estimated to be B1.0E-
6M 3OC12HSL. This result was coherent with previous studies
that had estimated that the extracellular concentration of
3OC12HSLisbetween1.0E-6and1.0E-4M(Pearsonetal,1995;
Charlton et al, 2000).
Characterization of the lysing device
As stated above, our system was designed to release pyocin S5
throughlysisupondetectionofP.aeruginosa.Todeterminethe
lysis activity of the system, we characterized the behavior of
the E7 lysis protein under the transcriptional control of the
sensing device before integrating both the pyocin S5 and E7
genes into the system. The E7 lysis gene was ligated down-
stream to the sensing device (i.e., pTetR-LasR-pLuxR-E7; the
plasmid map is shown in Supplementary Figure 1C) and its
performance was evaluated in the E. coli chassis over time by
measuring absorbance at OD600 at a range of concentrations of
3OC12HSL. Figure 3A shows that at 0 and 1.0E-8M 3OC12HSL,
the growth rates of E. coli underwent no noticeable transition
into a lysis state. However, at higher concentrations of
3OC12HSL (i.e., 1.0E-6 and 1.0E-4M), the cells exhibited a
signiﬁcant reduction in optical density, likely due to the lysis
activity. Our results imply that 1.0E-6M or higher concentra-
tions of 3OC12HSL cause observable cell lysis with a delay of
B120m. To verify the effect of the lysis, cell integrity was
examined with and without 1.0E-6M 3OC12HSL using ﬁeld-
emission scanning electron microscopy (FESEM). Figure 3B
shows that E. coli containing pTetR-LasR-pLuxR-E7 and
induced with 3OC12HSL appeared shriveled with corrugated
surface morphology, in contrast to the distinct ‘rod-like’
features of the cells that were not induced with 3OC12HSL.
Tofurtherconﬁrmthatthelysisactivitycanbesustainedinthe
ﬁnal system including pyocin S5, the morphology of E. coli
containing the ﬁnal system (i.e., pTetR-LasR-pLuxR-S5-pLuxR-
E7; Figure 1) was monitored using FESEM. Figure 3C shows
that E. coli cells having the ﬁnal system and induced with
3OC12HSL also appeared shriveled with corrugated surface
morphology, whereas E. coli cells having the ﬁnal system but
not induced with 3OC12HSL remained ‘rod-like’ in shape.
These observations were similar to that obtained in our earlier
experiment with E. coli containing pTetR-LasR-pLuxR-E7. This
result suggests that 3OC12HSL induced the lysis of the E. coli
containing the ﬁnal system.
In line with the overall objective of the E7 lysis device in
mediatingthe exportof pyocin, westudied theefﬁciencyofthe
lysis devicein theﬁnal systembymeasuring the amount of the
released protein. After induction with 1.0E-6M 3OC12HSL,
histidine-tagged S5 protein was puriﬁed by immobilized metal
afﬁnity chromatography from the ﬁltered supernatant and
analyzed by SDS–PAGE and Bradford assay. Figure 4A shows
that distinct bands that corresponded to pyocin S5 were
observed on the SDS–PAGE of the ﬁnal system (i.e., pTetR-
LasR-pLuxR-S5-pLuxR-E7), while no bands were seen in lanes
without the lysis device (i.e., pTetR-LasR-pLuxR-S5; the
plasmid map is shown in Supplementary Figure 1D). We
further validated the results by estimating the protein
concentrations in the supernatant with Bradford assay and
showed that the amount of pyocin released byour ﬁnal system
waseighttimeshigherthanthesystemwithoutthelysisdevice
(Figure 4B). The dynamic performance of the lysis device in
the ﬁnal system was characterized by an impulse release of
protein 2h after induction, followed by a steady-state
response.
Veriﬁcation of the ﬁnal system with the sensing,
killing, and lysing devices
We have so fardemonstrated that our engineered microbes are
able to sense natively produced AHL 3OC12HSL, which
subsequently triggers cell lysis. To further determine whether
the sensing of 3OC12HSL also leads to killing of P. aeruginosa
as designed, the growth of P. aeruginosa was monitored in the
presence of the engineered E. coli containing the ﬁnal system.
First, to determine the concentration of 3OC12HSL that causes
a signiﬁcant growth inhibition and conﬁrm that the concen-
tration falls within the range of concentrations of 3OC12HSL
naturallyproducedbyP.aeruginosa,theengineeredE.coliwas
exposed to commercial 3OC12HSL at 0, 1.0E-8, 1.0E-6, and
1.0E-4M, and the ﬁltered supernatants were added onto
P. aeruginosa-grown agars. We observed that the growth of
P. aeruginosawasclearlyinhibited bythe ﬁlteredsupernatants
of the E. coli cultures exposed to 1.0E-6 and 1.0E-4M
3OC12HSL, whereas very faint inhibition zones were observed
at 0 and 1.0E-8M, likely due to the basal expression of pyocin
S5 and E7 (Supplementary Figure 2A). Second, to further
conﬁrm the inhibition effects, P. aeruginosa was examined
upon exposure to the supernatant of the E. coli cultures with
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As seen under microscope, many P. aeruginosa cells exposed
to the supernatant of the engineered E. coli were stained with
the PI dye, which stains a dead cell, whereas those that were
incubated with the wild-type E. coli were mostly stained with
the SYTO 9 dye, which stains a live cell (Supplementary Figure
2B). This result suggests that our engineered E. coli carrying
the ﬁnal system can kill P. aeruginosa in response to as low as
1.0E-6M 3OC12HSL. Since our earlier estimation indicated
that the concentration of 3OC12HSL natively produced by
P. aeruginosa was B1.0E-6M, this outcome may imply that
thiskilling activity would be sustained against P. aeruginosa in
response to its producing 3OC12HSL.
Therefore, subsequently, to conﬁrm the killing activity by
the native 3OC12HSL produced by P. aeruginosa, the ﬁltered
supernatant of P. aeruginosa cultures was mixed with the
E. coli cultures, whose supernatant was then added to
P. aeruginosa-grown agars. Figure 5A shows that P. aeruginosa
growth was signiﬁcantly inhibited by the engineered E. coli
cultures exposed to the supernatant of P. aeruginosa cultures,
while neither with the wild-type E. coli cells nor without the
P. aeruginosa supernatant led to growth inhibition. This result
indicates that our ﬁnal system produces pyocin S5 and E7 in
response to the 3OC12HSL natively produced by P. aeruginosa,
which resulted in the killing of P. aeruginosa.
TofurthervisualizetheinhibitioneffectsonP.aeruginosaby
our engineered E. coli, P. aeruginosa cells were stained using
theLIVE/DEADcellviabilityassay.Figure5Bshowsthatmany
P. aeruginosa cells exposed to the supernatant of the
engineered E. coli induced with native 3OC12HSL were stained
with the PI dye, whereas the cells incubated with thewild-type
E. coli were mostly stained with the SYTO 9 dye (green). This
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system can kill P. aeruginosa in the presence of native
3OC12HSL produced by P. aeruginosa.
To verify that our engineered E. coli that contains the ﬁnal
system (i.e., pTetR-LasR-pLuxR-S5-pLuxR-E7) exerts a killing
activityagainst P. aeruginosa in a mixedculture, we monitored
the growth of P. aeruginosa co-cultured with the engineered
E. coli in the ratio 1:4. To determine the growth inhibition of
P. aeruginosa in the mixed culture, we used P. aeruginosa that
constitutively expresses GFP and E. coli that is without either
the pyocin S5 or E7 lysis devices as negative controls.
Figure 5C shows that the GFP expression level of the
P. aeruginosa co-cultured with the E. coli that carries the ﬁnal
system remained low and almost constant, whereas the GFP
level underwent an exponentially increase when P. aeruginosa
was cultured with the negative control E. coli systems.
Toverifytheefﬁciencyingrowthinhibition,wealsoperformed
CFU count on mixed cultures using P. aeruginosa that
was transformed with chloramphenicol-resistant plasmid.
Figure 5D shows that our engineered E. coli inhibited the
growth of P. aeruginosa by 499% while continuous growths
were apparent in P. aeruginosa co-cultured with incomplete
E. coli systems missing either the pyocin S5 or E7 lysis devices.
The result also implies that our engineered system was
activated only after the pathogen entered the late exponential
and stationary phase when the autoinducers were released
(Supplementary Figure 2C).
To examine the potential application of our engineered
system against a pseudo disease state of Pseudomonas, a static
bioﬁlm inhibition assay was performed by culturing
P. aeruginosa carrying a chloramphenicol-resistance plasmid
with the engineered E. coli. Figure 6A shows that our
engineered E. coli inhibited the formation of P. aeruginosa
bioﬁlmbycloseto90%.Thisobservationisinstarkcontrastto
the pyocin-resistant control strain PAO1 and pyocin-sensitive
clinical isolate ln7 subjected to treatment with E. coli having
the systems missing either the pyocin S5 or E7 lysis gene.
To visualize the extent of bioﬁlm inhibition, bioﬁlm cells
with green ﬂuorescence were grown in the presence of
engineered E. coli on glass slide substrate and examined with
confocal laser scanning microscopy (CLSM). Figure 6B shows
that the morphology of Pseudomonas bioﬁlm treated with the
engineered E. coli appeared sparse while elaborated honey-
combed structures were apparent in the control experiments.
This observation implies that our engineered E. coli has the
capability to inhibit bioﬁlm formation during the initial
attachment phase and prevent subsequent progression into
mature microcolonies. Collectively, our results suggest that
our engineered E. coli carrying the ﬁnal system, which
contains the sensing, killing, and lysing devices, can effec-
tively inhibit the growth of P. aeruginosa in both planktonic
and sessile states. Nonetheless, we recognize the need for
further extensive experimental studies in direct disease-
relevant models. In particular, future studies should examine
the in vivo efﬁcacy of the engineered E. coli in controlling the
growth of P. aeruginosa in infected murine models.
Conclusion
In summary, we engineered a novel biological system, which
comprises sensing, killing, and lysing devices, that enables
E. coli to sense and eradicate pathogenic P. aeruginosa strains
by exploiting the synthetic biology framework. We designed
and synthesized all the biological parts in compliance with the
BioBrick assembly standards. The sensing, killing, and lysing
devices were characterized to elucidate their functionalities,
which subsequently aided in the construction of the ﬁnal
system and the veriﬁcation of its designed behavior. Based on
the characterization and modeling results, we veriﬁed that the
sensing device had an optimal activity approximately in the
A
B
(i) (ii) (iii)
75
50
4.0 1.4
1.2
1.0
0.8
0.6
0.4
0.2
0.0
3.5
3.0
2.5
2.0
O
D
6
0
0
P
r
o
t
e
i
n
 
c
o
n
c
e
n
t
r
a
t
i
o
n
 
(

g
/
m
l
)
1.5
1.0
0.5
0.0
Cell growth of pTetR-
LasR-pLuxR-S5
His-tagged S5 of pTetR-
LasR-pLuxR-S5
His-tagged S5 of pTetR-
LasR-pLuxR-S5-pLuxR-E7
Cell growth of pTetR-
LasR-pLuxR-S5-pLuxR-E7
02
Time after induction (h)
46
(iv) (v) (vi) (vii) (viii)
Figure 4 Characterization results of the lysis device in the ﬁnal system using
3OC12HSL. (A) SDS–PAGE of (i, ii) total extracellular proteins and (iii–viii) IMAC
puriﬁed His-tagged S5 protein sampled from the extracellular supernatant. Total
extracellular proteins exported from (i) E. coli carrying pTetR-LasR-pLuxR-S5
(without lysis device) was signiﬁcantly lesser than that exported from (ii) E. coli
carrying pTetR-LasR-pLuxR-S5-pLuxR-E7 (the ﬁnal system) as indicated in
darker lanes of (ii) relative to (i). (iii–v): E. coli carrying pTetR-LasR-pLuxR-S5
(without lysis device) at 0, 2, and 4h after induction. (vi–viii) E. coli carrying
pTetR-LasR-pLuxR-S5-pLuxR-E7 (the ﬁnal system) at 0, 2, and 4h after
induction.TheresultsshowthatpyocinS5(57kDa;arrowed)wasonlydetectable
in lanes that corresponded to E. coli carrying the ﬁnal system and not in lanes of
E.coliwithoutthelysisdevice.LadderusedwasBio-Rad’sPrecisionPlusProtein
standards. (B) Characterization of lysis device in the ﬁnal system by optical
density (bar graphs) and concentration of pyocin released (lines) after induction.
The results show an impulse release of pyocin S5 at 2h after induction, followed
by a sustained steady-state release in the ﬁnal system (dotted lines). Optical
density of the ﬁnal system was characterized by an initial decrease at 2h after
induction, indicative of the onset of lysis, after which the regrowth of engineered
E. coli occurs (shaded bar). Correspondingly, the concentration of pyocin
released in E. coli without the lysis device (solid line) was 1/8 that of the ﬁnal
system with a continually increasing optical density (unshaded bar). Error bar
represents the standard deviation of two replicates. Source data is available for
this ﬁgure at www.nature.com/msb.
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the concentration of 3OC12HSL secreted by P. aeruginosa.W e
further conﬁrmed the activity of the killing and lysing devices
in response to this range of 3OC12HSL concentration. Finally,
we demonstrated that our engineered E. coli with the complete
system effectively kills P. aeruginosa in both planktonic and
bioﬁlm states when those two microbes were grown together.
As a proof of concept, E. coli, a natural inhabitant of the
gastrointestinal tract, was chosen as the chassis in this study.
The synthetic biology framework and genetic devices devel-
oped in this work could potentially be transferred into other
microbial chassis such as probiotics and residential microbes
of the upper respiratory tract (Brook, 2005; Charlson et al,
2010). Further, this study presents the possibility of engineer-
ing potentially beneﬁcial microbiota into therapeutic bioa-
gents to arrest Pseudomonas infection. Given the stalled
development of new antibiotics and the increasing emergence
of multidrug-resistant pathogens, this study provides the
foundational basis for a novel synthetic biology-driven
antimicrobial strategy that could be extended to include other
pathogens such as Vibrio cholera and Helicobacter pylori.
Materials and methods
Strains and media
All cells involved in cloning and characterization experiments are
E. coli TOP10 (Invitrogen) unless otherwise stated. Commercial
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pLuxR-S5 shows an exponential increase in the ﬂuorescence readings, whereas the mixed culture with E. coli carrying pTetR-LasR-pLuxR-S5-pLuxR-E7 (the ﬁnal
system) exhibited no increase in the readings. This suggests that the growth of P. aeruginosa was signiﬁcantly inhibited in the mixed culture with engineered E. coli
carrying the ﬁnal system. PAO1, which pyocin S5 was derived from, was included as a negative control. Error bar represents the standard deviation of six replicates.
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represents the standard deviation of three replicates. Source data is available for this ﬁgure at www.nature.com/msb.
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for cloning and inhibition studies unless otherwise stated. Supple-
mented M9 (M9 salts, 1mM thiamine hydrochloride, 0.4% glycerol,
0.2% casamino acids, 0.1M MgSO4, 0.5M CaCl2) was used as the
medium for the characterization. Ampicillin (100mg/ml) was added to
the culture media for antibiotic selection where appropriate. Homo-
serine lactone (3OC12HSL; Sigma-Aldrich) was used for characteriza-
tion experiments. All restriction and ligation enzymes were purchased
fromNewEnglandBiolabs(NEB). SupplementaryTable1summarizes
all plasmids, Biobrick parts, and devices used in this study. Genetic
mapping of representative engineered constructs is illustrated in
Supplementary Figure 1.
System assembly
The genetic constructs developed in this study were assembled using
standard synthetic biology protocols (Canton et al, 2008). Brieﬂy, for
front insertion of Biobrick parts, puriﬁed insert and vector plasmids
were digested with EcoRI/SpeI and EcoRI/XbaI respectively. For back
insertion to upstream vector, the insert and vector plasmids were
digested with XbaI/PstI and SpeI/PstI in that order. Digestedfragments
wereseparatedbyDNAgelelectrophoresisandligatedwithNEBQuick
Ligase in accordance with the manufacturer’s instructions. Plasmids
from chemically transformed cells were puriﬁed by afﬁnity columns
and veriﬁed by DNA sequencing.
Characterization of pTetR-LasR-pLuxR-GFP with
3OC12HSL
Single colonies of pTetR-LasR-pLuxR-GFP (Top10) were each inocu-
lated into 5ml of prewarmed supplemented M9 ampicillin for
overnight culture in a shaking incubator at 371C. After overnight
growth, the cultures were diluted to OD600 of 0.002 and allowed to
incubate further to OD600 of 0.5 or 5.0E7cfu/ml under the same
condition. Cultures were then transferred into a transparent, ﬂat-
bottom 96-well plate in triplicate aliquots of 200ml for induction with
3OC12HSL at varying molar concentrations (0, 5.0E-10, 1.0E-9, 5.0E-9,
1.0E-8, 5.0E-8, 1.0E-7, 2.5E-7, 5.0E-7, 1.0E-6, 5.0E-6, 1.0E-6, 5.0E-5,
and1.0E-4M).Theplatewas incubated at371C withrapid shakingina
microplate reader (Biotek) and assayed for green ﬂuorescence. Time-
series ﬂuorescence and OD600 data were obtained at intervals of 10m
foratotalruntimeof3h.TheresultwaszeroedwithsupplementedM9
to remove background ﬂuorescence and OD600. A relative GFP
production rate was derived as a ratio of background subtracted green
ﬂuorescence to OD600 value. A time-averaged GFP synthesis rate was
obtained by averaging the relative GFP production rates between 20
and 80m after induction with 3OC12HSL. The experimental results
were ﬁtted using an empirical mathematical model (Hill equation),
y ¼ A þ
B½C12 
n
Cn þ½ C12 
n ð1Þ
Equation 1 models GFP synthesis rate (y) as a function of input
concentration of 3OC12HSL ([C12]). The four parameters (A, B, C, n)
were estimated to obtain the best ﬁt curve by performing a non-linear
curve ﬁtting using the experimental results. This curve ﬁtting was
performed using MATLAB Curve Fitting Toolbox (The Mathworks,
Natwick, MA, USA).
Detection of the native autoinducer produced by
P. aeruginosa
GFP production rates induced by 3OC12HSL natively produced from
P. aeruginosa were measured with pTetR-LasR-pLuxR quorum sensor
as described above. Brieﬂy, overnight cultures of pTetR-LasR-pLuxR-
GFP (Top10) were diluted in Supplemented M9. Diluted Pseudomonas
cultures were grown to a late logarithmic phase and ﬁltered with a
ﬁlter membrane (0.22mm). Sterile ﬁltrates containing 3OC12HSL were
mixedwithpTetR-LasR-pLuxR-GFPculturetoactivateGFPproduction.
Theresultant mixtures were transferred into a transparent, ﬂat-bottom
96-well plate in triplicate aliquots of 200ml to be assayed for GFP
production rates in a microplate reader (Biotek) at 371C with rapid
shaking.Theratesobtainedwerethencomparedwiththe Hillfunction
mathematical model derived earlier using 3OC12HSL to estimate the
native 3OC12HSL concentration from P. aeruginosa ln7.
Characterization of lysis device with 3OC12HSL
Overnight cultures of pTetR-LasR-pLuxR-E7 (Top10) were diluted in
supplemented M9 and harvested at an OD600 of 0.5. The resultant
cultures were transferred into a transparent, ﬂat-bottom 96-well plate
in triplicate aliquots of 200ml for induction with 3OC12HSL at varying
concentrations (i.e., 0, 1.0E-8, 1.0E-6, and 1.0E-4M). The plate was
incubated at 371C with rapid shaking in a microplate reader (Biotek)
and assayed for cell turbidity. Time-series absorbance at OD600 was
obtained at intervals of 10m for a total run time of 6h. The result was
zeroed with supplemented M9 to remove background absorbance.
FESEM assay
To examine the effect of E7 lysis protein on cell morphology, re-
inoculated cultures of pTetR-LasR-pLuxR-E7 (Top10) and pTetR-LasR-
pLuxR-S5-pLuxR-E7 (Top10) were induced with 1.0E-6M 3OC12HSL at
OD600 of 0.5 and cultured for 2h. Cell pellets collected after
centrifugation at 4000r.p.m. for 15m were washed with 0.1M sodium
cacodylate (pH 7.4) three times before ﬁxation with 2.5% glutaralde-
hyde in 0.1M sodium cacodylate for 2h of incubation at 41C. Cell
pellets were further washed three times with sodium cacodylate after
ﬁxation and resuspended in 0.1M sodium cacodylate (volume
depends on cell amount). In all, 2ml of sample was loaded onto PEI-
coated silicon slide followed by incubation at 251C for 30m. The
loaded silicon slide was ﬁxed in 1% osmium tetraoxide in 0.1M
sodium cacodylate at 251C for 90m. Silicon slide was then dehydrated
in serial concentrations of absolute ethanol (37, 67, 95% and three
times of 100%) for 15m each before drying in a vacuum evaporator
overnight. Coating of silicon slide was performed with 20nm of gold–
palladium alloy (60:40) and examined using a ﬁeld-emission scanning
electron microscope (JSM-6700F FESEM) at 10kV
Characterization of lysis device by protein release
in engineered E. coli
To characterize the efﬁciency of the lysis device in mediating pyocin
release, pTetR-LasR-pLuxR-S5-pLuxR-E7 and pTetR-LasR-pLuxR-S5
plasmids were ﬁrst labeled with hexa-histidine tags on the 30 terminus
of S5 genewithpfu polymerase (Promega)and transformedinto E. coli
Top10. Overnight cultures of the His-tag version of pTetR-LasR-pLuxR-
S5-pLuxR-E7 and pTetR-LasR-pLuxR-S5 were then diluted in LB and
harvested at an OD600 of 0.7. The collected cultures were induced with
1.0E-6M 3OC12HSL and incubated for 6h in a shaking ﬂask culture set
at 371C and 170rpm. At regular intervals of 2h, cell cultures were
drawn and ﬁlter sterilized (0.22mm). The ﬁltered cultures were mixed
with 1/10 volume of 100% (w/v) trichloroacetic acid (Sigma-Aldrich)
and incubated on ice for an hour to allow protein precipitation, before
being washed with an equal volume of acetone. Precipitated proteins
were reconstituted in 1ml of reconstitution solvent (1  PBS, 30mM
imidazole and 4M urea; pH 6.0) and puriﬁed by immobilized metal
afﬁnity chromatography using Vivapure miniprep MC (Sartorius
Stedim Biotech GmbH) in accordance to the manufacturer’s instruc-
tion. Finally, puriﬁed pyocin proteins were analyzed by SDS–PAGE
(Chen and Leong, 2009; Huang et al, 2009) and Bradford assay
(Bradford, 1976).
Overlay inhibition assay with 3OC12HSL and the
ﬁnal system
Overnight cultures of pTetR-LasR-pLuxR-S5-pLuxR-E7 (Top10),
P. aeruginosa ln7 and PAO1 were diluted in LB and harvested at
OD600 of 0.7 and 0.2 separately. Collected cultures of pTetR-LasR-
pLuxR-S5-pLuxR-E7 (Top10) were induced with varying molar
concentrations of 3OC12HSL (0, 1.0E-8, 1.0E-6, and 1.0E-4M) and
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(0.22mm). In all, 30ml of sterile ﬁltrate from each induced sample
containing soluble S5 was spotted onto trypticase soy agar (TSA) plate
in triplicates. Upon drying of spots, 0.1ml of ln7 at OD600 of 0.2 in soft
agar (1% peptone, 0.5% agar) prewarmed at 551C was thinly ﬁlmed
over the spotted TSA and allowed to dry completely. Resultant TSA
plate was then incubated for 6h at 371C before image analysis with
Bio-Rad ChemiDoc XRS. To evaluate the effectiveness of the
engineered system coupled with the sensing function, overnight
culture of P. aeruginosa ln7 was also harvested at OD600 of 1.0 after
redilution. The culture was ﬁltered with a ﬁlter membrane (0.22mm)
and the sterile ﬁltrate obtained, containing planktonic 3OC12HSL was
used to induce pTetR-LasR-pLuxR-S5-pLuxR-E7 (Top10). These proce-
dures were repeated to capture inhibitory images for the engineered
system that was activated by 3OC12HSL natively produced from
P. aeruginosa.
Co-culturing of the engineered E. coli and
P. aeruginosa
GFP reporter plasmid pMRP9-1 and chloramphenicol-resistant plas-
mid pAWG1.1 were transformed into P. aeruginosaln7 and PAO1 using
a method described before (Choi et al, 2006). Overnight cultures of P.
aeruginosa (ln7/PAO1 with pMRP9-1), pTetR-LasR-pLuxR-S5 (Top10),
pTetR-LasR-pLuxR-E7 (Top10), and pTetR-LasR-pLuxR-S5-pLuxR-E7
(Top10) were diluted and harvested at an OD600 of 1.0. pTetR-LasR-
pLuxR-S5-pLuxR-E7 (Top10) was added to ln7 or PAO1 in the ratio 4:1
toobtainamixedculturewithanoverallcelldensityof1.0E8cfu/mlin
25ml of MHB. The resultant mixture was grown for 15h in a shaking
ﬂask culture set at 371C and 170rpm. For ﬂuorescence assays, the
mixed culture was transferred into a transparent, ﬂat-bottom 96-well
plates in aliquots of 200ml and assayed for background subtracted
green ﬂuorescence in a microplate reader (Biotek) at regular intervals
of 3h. The same procedures were repeated for pTetR-LasR-pLuxR-S5
(Top 10) and pTetR-LasR-pLuxR-E7 (Top 10) as negative controls. For
cellviabilityassays,aliquotsofP.aeruginosainthemixedculturewere
quantiﬁed by CFU count on chloromphenicol selective agar plates at
regular intervals of 5h. The same procedures were repeated for pTetR-
LasR-pLuxR-S5(Top10)andpTetR-LasR-pLuxR-E7(Top10)asnegative
controls. Percentage survival of planktonic P. aeruginosa was
determined as follows:
Percentage cell survival
¼
CFU of P: aeruginosa in treated sample at time t 100
CFU of P: aeruginosa treated with WT E: coliattimet
ð2Þ
Live and dead ﬂuorescent microscopy
Overnight cultures of ln7 and pTetR-LasR-pLuxR-S5-pLuxR-E7 (Top10)
were diluted in LB and harvested at an OD600 of 0.5 and 1.0,
respectively. 3OC12HSL from ln 7 was obtained after passing ln7
culture througha ﬁlter membrane(0.22mm)and the sterileﬁltratewas
used to induce expression of engineered system by mixing it with
pTetR-LasR-pLuxR-S5-pLuxR-E7 (Top10) in 1:1 mixing ratio to a total
volume of 2ml. The resultant culture was grown for 3h and ﬁltered
with a similar membrane to obtain sterile S5 ﬁltrate. The ﬁltrate was
mixed with ln7 at OD600 of 1.0 in 1:1 mixing ratio to a total volume of
2ml and incubated for 3h. One microliter of the ﬁnal culture was
stained with bacterial viability kit (Invitrogen) according to the
manufacturer’s instruction and analyzed with a ﬂuorescent micro-
scope (Zeiss Axio Scope A1).
Bioﬁlm inhibition assay
P. aeruginosa (ln7/PAO1 with pAWG1-1) conferred with chloramphe-
nicol resistance was mixed with pTetR-LasR-pLuxR-S5-pLuxR-E7
(Top10) in the ratio 1:4 to obtain a mixed culture with an overall cell
density of 1.0E8cfu/ml in 6ml of MHB. The resultant mixture was
transferred to the wells of a polystyrene microtiter plate (Iwaki) in
aliquots of 1ml each and grown at 371C and 150rpm. After 18h of
growth, bioﬁlm on the microtiter plate was rinsed and recovered in
fresh MHB by sonication and quantiﬁed by CFU count on chloram-
phenicol-selective plate (100mg/ml). The same procedures were
repeated for ln7 treated with pTetR-LasR-pLuxR-S5 (Top10) and
pTetR-LasR-pLuxR-E7 (Top10), and PAO1 treated with pTetR-LasR-
pLuxR-S5-pLuxR-E7 as negative controls. Percentage survival of P.
aeruginosa bioﬁlm was determined as follows:
Percentage biofilm survival
¼
CFU of P: aeruginosa biofilm in treated sample 100
CFU of P: aeruginosa biofilm in treated with WT E: coli
ð3Þ
Confocal microscopy of bioﬁlm
Mixed bacteria cultures of P. aeruginosa (ln7 with pMRP9-1) and
engineered E. coli systems were grown in MHB in 50ml tubes
containing sterile glass slide. Bioﬁlm developed on the glass slides
after 18h of growth was rinsed in PBS, dried, and visualized by
confocal laserscanning microscopy (Zeiss LSM 510). Collected Z-stack
bioﬁlm images were reconstructed using Zeiss 2.5D software.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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